Dr. Joyal Shah
M.D. (Internal Medicine),
Fellow in Cardiology

Mobile: 98253 19645
   
NAME Dr. Joyal Shah
SEX Male
PERMANENT ADDRESS

Residence:
Flat No. 83, Shaligram-II,
Opp. Hilton Row House,
Prahladnagar,
Ahmedabad.
Mobile: 98253 19645

OFFICE ADDRESS:
CIMS Hospital
Nr. Shukan Mall,
Off Science City Road,
Sola,Ahmedabad 380 060 (INDIA)

DATE OF BIRTH 27th September, 1974
PREVIOUS AFFILIATIONS
  • Associate cardiologist, Sterling Hospital, Ahmedabad.
    Oct 2003 to Feb 2004.
  • Fellow in cardiology, Sterling hospital, Ahmedabad
    Oct 2001 to Oct 2003.
  • Associate Cardiologist - Sal Hospital.
  • DNB Fellow - Sal Hospital.
CURRENT AFFILIATIONS
  • Consultant & International Cardiologist - CIMS.
  • Board Member – CCC (Clinical Cardiovascular
    Consultant).

LICENSE NO
G – 10482 (M. D.)

Qualifications
  • Diplomate of National Board (DNB) Cardiology - India.
  • MD (Internal Medicine), M.P. Shah Medical College,
    Jamnagar 1998 – 2001.
  • MBBS, M.P. Shah Medical College, Jamnagar 1992 – 1997.
  • HSC, M.K. Higher Secondary School, G.S.E.B.1992.
  • SSC, M.K. Higher Secondary School, G.S.E.B. 1990.

Visiting Cardiologist
  • Ashirwad Hospital – Himmatnagar – Gujarat.
  • Sanjeevani Hospital – Modasa – Gujarat.
  • Arihant Clinic – Ider - Gujarat.

PROFESSIONAL EXPERIENCE
  • Full time Consultant Physician at Jalaram hospital, Meghraj, Gujarat.
  • Assistant Professor of Medicine at Sainath Homeopathic College,
    Bopal, Ahmedabad.
  • Fellow in Cardiology at Sterling hospital,
    Gurukul, Ahmedabad. Oct 2001 to Oct 2003.
  • Associate cardiologist at sterling Hospital Oct 2003 to Feb 2004.
  • Associate cardiologist at SAL from March 2004 to August 2005.
  • Consultant & International Cardiologist – CIMS Hospital.
  • Clinical Cardio Vascular Consultant – The Heartcare Clinic, Ahmedabad.

PAPERS AND PUBLICATIONS
  • Neuroleptic Malignant Syndrome.
  • EMG and NCV in Diabetes.
  • Snake bite and its complications.
  • Gullian Barrie Syndrome (GBS).

CONFERENCES
  • API January 1999, Jaipur.
  • APG 1997, Jamnagar.
  • APG 1999, Karamsad.
  • Cardiology Conference (update in cardiology),
    February 2000, Ahmedabad.
  • Joint International Conference 2005, Ahmedabad.
 
Actively Participated In Echocardiography And Clinical Diagnostic Camps.
 
CLINICAL RESEARCH ASSISTED
  1. Effect of Folate treatment on Homocysteinemia in cardiac patients: A Prospective Study.
  1. Pharmacoepidemiology and Risk factors of Hypertension in Gujarat.
  1. Reversal of slow or no- reflow During Percutaneous Transluminal Coronary Angioplasty Using Boluses of Intracoronary Adenosine and Sodium Nitroprusside in combination.
  1. Acute Results of Intermediate – term follow up of Percutaneous Transluminal Coronary Angioplasty with Cardioprotection by Balloon Occlusion Distal Protection Device.
  1. Effect of Tirofiban HCl in Patients with Acute Coronary Syndrome and its comparison with other GPIIb/IIIa antagonists such as Abciximab and Eptifibatide .
  1. Revascularization Utilizing Balloon Protection in Acute Coronary ischemic Syndrome- An International Registry.
  1. An International Registry of CYPHER TM-Sirolimus eluting stent.
  1. High prevalence of Renal Artery Stenosis in Hypertensive patients with Triple vessel Coronary Artery Disease.
  1. Effects of Combination of Statins and Fenofibrates with Acute Coronary Syndrome undergoing Percutaneous Coronary Intervention.
  1. Effect of Pioglitazone and its combination with Statins in Coronary Artery Disease patients with Hsyperinsulinemia.
  1. Comparison of Drug eluting stent with S7 stent.
  1. Assessment of Risk factors for Coronary Artery Disease.
  1. Effect of Niacin treatment on hyperlipoproteinemia in Coronary Artery Disease patients.
  1. Beneficial effects of Distal Protection Device in reducing the use of Intracoronary Vasodialators and Glycoprotein IIb/IIIa receptor antagonists during Percutaneous Coronary Interventions.
  1. Comparison of Total Procedural time involved in Primary PCI with or without the use of Distal Balloon Protection system in Thrombotic Coronary lesions. (RAPID trial- Revascularization in Acute myocardial infarction using Percusurge In Distal protection).
  1. Effect of Metoprolol CR/XL on Pulmonary Artery Pressure in Patients with Heart Failure measured using First in Human implantable device responding to ultrasonic signal.
  1. Effect Of Metoprolol CR/XL On Diurnal Variation In Pulmonary Artery Pressure Measured Non-invasively Using First In Human Implant Responding To Ultrasonic Signals.
  1. First in Human Implanted Device in Pulmonary Artery Using Acoustic Telemetry Based on Non-Invasive Ultrasound Activation and Communication.
INTERNATIONAL CLINICAL TRIALS
  1. LMWH in Acute Coronary Syndrome.
  1. LMWH in Acute Myocardial Infarction.
  1. Angiotensin Receptor Blocker in Paediatric Hypertension.
  1. Prostacyclin Analogue in Pulmonary Hypertension.
  1. Newer generation statin in Hyperlipidemia.
  1. Coronary Sinus stent like device for retroperfusion in Coronary Artery Disease.
  1. Implantable Ultrasonic device for PA pressure measurement in Heart failure.
  1. Aspiration catheter in Acute Myocardial Infarction.
  1. Anticoagulant therapy in non-valvular atrial fibrillation.
  1. POLYCAP Study.
  1. Phase II study for patient having Dyslipidemia.
  1. Endeavor versus Cypher stenting Trial.
  1. Cangrelor to Clopidogrel in subject who require Percutaneous Coronary Intervention.
  1. New Guidewire for Crossing Total Occlusions in Coronary Arteries.
  1. high loading dose regimen of Clopidogrel versus standard dose in patients with unstable angina or non-ST segment elevation myocardial infarction.
  1. AZD6140 Compares with Clopidogrel for prevention of Vascular Events in patients with Non-ST or ST Elevation Acute Coronary Syndromes (ACS) [PLATO – A study of PLATelet inhibition and Patient Outcomes.
  1. GP IIb/IIIa Inhibition in Non-ST-segment Elevation Acute Coronary Syndrome.
  1. Post marketing Survelliance for clinical and angiographic evaluation of Corel C stent.
TOP  
 
 
   © Copyright 2010 The Heart Care Clinic